The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Am J Gastroenterol. 2012 Jun;107(6):811-26. doi: 10.1038/ajg.2012.128.
No abstract available

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alcohol Drinking / adverse effects
  • Bariatric Surgery
  • Biopsy
  • Child
  • Disease Management
  • Fatty Liver / diagnosis*
  • Fatty Liver / epidemiology
  • Fatty Liver / etiology
  • Fatty Liver / physiopathology
  • Fatty Liver / therapy*
  • Fatty Liver, Alcoholic / diagnosis
  • Fatty Liver, Alcoholic / therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hypoglycemic Agents / administration & dosage
  • Incidence
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / therapy
  • Mass Screening
  • Non-alcoholic Fatty Liver Disease
  • Prevalence
  • Risk Factors
  • Risk Reduction Behavior
  • Severity of Illness Index
  • United States / epidemiology
  • Vitamin E / administration & dosage
  • Weight Loss

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Vitamin E